June 25, 2020
Leaflet on APDS just published
IPOPI is glad to announce the publication of a new leaflet on APDS – Activated PI3K Delta syndrome! In this new publication you can learn more about this rare genetic PID, how it is diagnosed and its treatment options.
APDS has a wide range of symptoms and severity but sequencing of the genes involved provides a definitive diagnosis and subsequent choice of appropriate treatment. It causes hypogammablobulinemia often seen in other conditions, among which Common Variable Immune Deficiency (CVID), and it can mimic Hyper IgM, so, patients with these diagnosis and additional symptoms of APDS can be referred for further testing.
IPOPI is pleased to make this leaflet available in English and expects that translated versions will soon be produced with the invaluable help of its national member organisations (NMOs).
IPOPI wishes to thank Novartis and Pharming for their support towards the production of this leaflet!
